Generic drungs' share in the pharmaceutical industry's market sales in Finland stood at 18 percent as of 2021. Over the sown period, the market share of generics in Finland declined by 6.2 percent since 2016.
Market share of generics in Finland from 2016 to 2021
‘Generics’ are defined as medicines based on active substances that are out of patent and which are marketed under different names from that of the original branded medicines.
Share of generics and biosimilars in pharmacy market sales.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
EFPIA. (June 29, 2023). Market share of generics in Finland from 2016 to 2021 [Graph]. In Statista. Retrieved January 06, 2025, from https://www.statista.com/statistics/1413505/finland-pharmaceutical-market-generics-share/
EFPIA. "Market share of generics in Finland from 2016 to 2021." Chart. June 29, 2023. Statista. Accessed January 06, 2025. https://www.statista.com/statistics/1413505/finland-pharmaceutical-market-generics-share/
EFPIA. (2023). Market share of generics in Finland from 2016 to 2021. Statista. Statista Inc.. Accessed: January 06, 2025. https://www.statista.com/statistics/1413505/finland-pharmaceutical-market-generics-share/
EFPIA. "Market Share of Generics in Finland from 2016 to 2021." Statista, Statista Inc., 29 Jun 2023, https://www.statista.com/statistics/1413505/finland-pharmaceutical-market-generics-share/
EFPIA, Market share of generics in Finland from 2016 to 2021 Statista, https://www.statista.com/statistics/1413505/finland-pharmaceutical-market-generics-share/ (last visited January 06, 2025)
Market share of generics in Finland from 2016 to 2021 [Graph], EFPIA, June 29, 2023. [Online]. Available: https://www.statista.com/statistics/1413505/finland-pharmaceutical-market-generics-share/